SWITCH PATTERNS AND TOTAL COSTS IN BIOLOGIC-NAIVE PATIENTS INITIATING APREMILAST OR A BIOLOGIC FOR THE TREATMENT OF PSORIASIS

被引:0
|
作者
Wu, J. [1 ]
Pelletier, C. [2 ]
Ung, B. [2 ]
Tian, M. [2 ]
Ni, Q. [2 ]
Curtis, J. R. [3 ]
机构
[1] Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA
[2] Celgene Corp, Summit, NJ USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
关键词
D O I
10.1016/j.jval.2018.09.2523
中图分类号
F [经济];
学科分类号
02 ;
摘要
PSS23
引用
收藏
页码:S426 / S426
页数:1
相关论文
共 50 条
  • [1] Real-world switch patterns and healthcare costs in biologic-naive psoriasis patients initiating apremilast or biologics
    Wu, Jashin J.
    Pelletier, Corey
    Ung, Brian
    Tian, Marc
    Khilfeh, Ibrahim
    Curtis, Jeffrey R.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (11) : 767 - 779
  • [2] SWITCH PATTERNS AND TOTAL HEALTHCARE COSTS IN BIOLOGIC-NAIVE PATIENTS INITIATING APREMILAST OR A BIOLOGIC FOR THE TREATMENT OF PSORIATIC ARTHRITIS: RESULTS FROM A US CLAIMS ANALYSIS
    Curtis, J. R.
    Pelletier, C.
    Ung, B.
    Tian, M.
    Ni, Q.
    Wu, J.
    [J]. VALUE IN HEALTH, 2018, 21 : S293 - S294
  • [3] Treatment patterns and costs among biologic-naive patients initiating apremilast or biologics for psoriatic arthritis
    Feldman, Steven R.
    Pelletier, Corey L.
    Wilson, Kathleen L.
    Mehta, Rina K.
    Brouillette, Matthew A.
    Smith, David
    Bonafede, Machaon M.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (09) : 699 - 708
  • [4] Real-world treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriasis
    Wu, Jashin J.
    Pelletier, Corey
    Ung, Brian
    Tian, Marc
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (04) : 365 - 371
  • [5] Switch Rates and Total Cost of Care Associated with Apremilast and Biologic Therapies in Biologic-Naive Patients with Plaque Psoriasis
    Kaplan, David L.
    Ung, Brian L.
    Pelletier, Corey
    Udeze, Chuka
    Khilfeh, Ibrahim
    Tian, Marc
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2020, 12 : 369 - 377
  • [6] Real-world US healthcare costs of psoriasis for biologic-naive patients initiating apremilast or biologics
    Feldman, Steven R.
    Pelletier, Corey L.
    Wilson, Kathleen L.
    Mehta, Rina K.
    Brouillette, Matthew A.
    Smith, David
    Bonafede, Machaon M.
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (01) : 45 - 54
  • [7] Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
    Wu, Jashin J.
    Pelletier, Corey
    Ung, Brian
    Tian, Marc
    Khilfeh, Ibrahim
    Curtis, Jeffrey R.
    [J]. ADVANCES IN THERAPY, 2020, 37 (05) : 2098 - 2115
  • [8] COMPARISON OF TREATMENT SWITCHING AMONG BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGIC TREATMENT: RESULTS FROM A US CLAIMS DATABASE
    Kaplan, D.
    Ung, B.
    Pelletier, C.
    Udeze, C.
    Tian, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S364 - S364
  • [9] Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis
    Jashin J. Wu
    Corey Pelletier
    Brian Ung
    Marc Tian
    Ibrahim Khilfeh
    Jeffrey R. Curtis
    [J]. Advances in Therapy, 2020, 37 : 2098 - 2115
  • [10] REAL-WORLD COSTS IN BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE
    Kaplan, D.
    Ung, B.
    Pelletier, C.
    Udeze, C.
    Tian, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S888 - S888